Iván Bontempi - Concepedia

Author

Iván Bontempi

Also Known As

Bontempi, Iván Alejandro, I Bontempi, Ivan A. Bontempi, Ivan Bontempi, Iván A. Bontempi, Iván Alejandro Bontempi, Iván Bontempi

Publications

341

Citations

H-Index

Concepts

All Affiliations

Universidad Nacional del Litoral National University of Rosario Consejo Nacional de Investigaciones Científicas y Técnicas University of Chile

About

Iván Bontempi is an author at Universidad Nacional del Litoral specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	125
2	Immunology	4	4	92
3	Microbiology	1	1	14
4	Pharmacology	1	1	15
5	Autoimmune Disease	1	1	20

Iván Bontempi

Publications

302

Citations

H-Index

Page 1

	Year	Citations
Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease Iván Bontempi, Miguel Hernán Vicco, Gabriel Cabrera, Vaccine VaccinologyVaccinationVaccine DevelopmentExperimental Chagas DiseaseVaccine Target	2015	45
Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype Estefanía Prochetto, Carolina Roldán, Iván Bontempi, Oncotarget	2017	33
Development and assessment of a new cage-like particle adjuvant Daiana Bertona, Nazarena Pujato, Iván Bontempi, Journal of Pharmacy and Pharmacology	2017	29
Genotyping of Trypanosoma cruzi Sublineage in Human Samples from a North-East Argentina Area by Hybridization with DNA Probes and Specific Polymerase Chain Reaction (PCR) Cristina Diez, Virginia Lorenz, S. Ortíz, American Journal of Tropical Medicine and Hygiene	2010	27
Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype Ingrid M. Quintana, Martín Espariz, Silvina R. Villar, Frontiers in Microbiology	2018	27
Trans-Sialidase Overcomes Many Antigens to be Used as a Vaccine Candidate Against <i>Trypanosoma Cruzi</i> Iván Bontempi, Pedro Fleitas, Alexia Ayelén Poato, Immunotherapy	2017	25
Assessment of Cross-reactive Host-pathogen Antibodies in Patients With Different Stages of Chronic Chagas Disease Miguel Hernán Vicco, Franco Ferini, Luz Rodeles, Revista Española de Cardiología (English Edition) Chronic Chagas DiseaseAutoimmune DiseaseHumoral ResponseImmunologySerologic Testing	2013	20
Recombinant <i>Mycobacterium bovis</i> BCG is a promising platform to develop vaccines against <i>Trypansoma cruzi</i> infection Iván Bontempi, Karla Leal, Estefanía Prochetto, Clinical & Experimental Immunology	2020	20
Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection Estefanía Prochetto, Iván Bontempi, Luz Rodeles, Acta Tropica VaccinationAfrican TrypanosomiasisParasitic ProtozoaTherapeutic VaccineMedicine	2022	19
Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi Juan Cruz Gamba, Carolina Roldán, Estefanía Prochetto, Frontiers in Cellular and Infection Microbiology	2021	16

Page 1